Shield Therapeutics, a pharmaceutical company focusing on iron deficiency treatments, has reported a significant increase in revenues for the year 2023. The company’s sales of its Accrufer/Feraccru iron deficiency treatment
All posts tagged in Shield Therapeutics
1Article
- Home
- Shield Therapeutics
Recent Posts
- National Lottery Revenue Shortfall Threatens 8 Billion Pound Hole in UK Treasury
- China Imposes Sanctions on Boeing Following 11 Billion Dollar Taiwan Arms Package
- Weight Loss Medications Demonstrate Significant Impact on Alcohol Consumption Patterns
- Asda Sells Supermarkets for 600 Million Pounds to Reduce Debt Pile
- Cinema Operators Pursue Premium Strategy as UK Box Office Targets Pre Pandemic Recovery
- British Mobile Tech Unicorn Nothing Remains Non Committal on London IPO Plans
- Boxing Day Sales Expected to Fall by 1 Billion Pounds Amid Economic Pressures
- Hedge Funds Position Against UK Retail Stocks Ahead of Christmas Trading Results
- UK Set to Become Fifth Largest Global Economy by 2040
- UK Living Standards Projected to Fall Behind Malta by 2035
- Rising Artificial Intelligence Infrastructure Costs Drive Consumer Price Increases Across Multiple Sectors
- UK Live Music Industry Faces Existential Threat as Grassroots Venues Struggle Beneath Supertour Boom
- US Economy Expands 43 Per Cent in Q3 2025 Outpacing G7 Peers
- Gold and Silver Rally to Unprecedented Levels as Market Dynamics Shift
- South Korea Transforms Gaming Industry Into Major Economic Export Powerhouse
- UK Electric Car Charger Rollout Slows Amid Policy Uncertainty and Investment Concerns in 2025
- UK Government Deploys Over One Million Pounds on Influencer Marketing Strategy Since 2024
- Poundland Draws Emergency Overdraft Amid Deepening Retail Crisis
- Petrofac North Sea Operations Acquired by CBI Securing 3000 UK Energy Jobs
- BP Divests Castrol Majority Stake in Strategic Refocus 2025
- The Second China Shock and the Growing Threat to European Industry
- Four day week warning issued to English local councils by government
- Ryanair fined €256m euros by Italian regulator for blocking online travel agents
- Scottish whisky sector faces supply glut amid sliding sales and tariffs
- European Electric Car Sales Surge as Tesla Loses Ground in Key Markets
- Glastonbury Profits Surge as Iconic Festival Fuels Record Charitable Giving
- Videndum shares plunge as refinancing plan dilutes investor stakes
- Novo Nordisk gains edge as US approves weight loss pill
- Bet365 Chief Denise Coates Earns £280 Million Despite Decline In Profits
- Private equity duo receive lengthy bans over banking system exploitation
